Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neurobiology of Disease

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.nbd.2015.01.006PMID 25680941
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations

  2014cited by this paper
• Oligodendrocyte Dynamics in the Healthy Adult CNS: Evidence for Myelin Remodeling

  2013cited by this paper
• A regenerative approach to the treatment of multiple sclerosis

  2013cited by this paper
• Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy

  2013cited by this paper
• M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination

  2013cited by this paper
• Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis

  2012cited by this paper
• Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach

  2012cited by this paper
• Fingolimod for multiple sclerosis.

  2012cited by this paper
• Animal models of multiple sclerosis: the good, the bad and the bottom line

  2012cited by this paper
• FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination

  2012cited by this paper
• Differential Modulation of the Oligodendrocyte Transcriptome by Sonic Hedgehog and Bone Morphogenetic Protein 4 via Opposing Effects on Histone Acetylation

  2012cited by this paper
• Megalin mediates the influence of sonic hedgehog on oligodendrocyte precursor cell migration and proliferation during development

  2012cited by this paper
• Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo.

  2011cited by this paper
• Cells of the oligodendroglial lineage, myelination, and remyelination.

  2011cited by this paper
• Enhancing remyelination in disease--can we wrap it up?

  2011cited by this paper
• Fingolimod modulates microglial activation to augment markers of remyelination

  2011cited by this paper
• Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis

  2011cited by this paper
• Differential Proliferation Rhythm of Neural Progenitor and Oligodendrocyte Precursor Cells in the Young Adult Hippocampus

  2011cited by this paper
• Inhibition of CNS Remyelination by the Presence of Semaphorin 3A

  2011cited by this paper
• The complex world of oligodendroglial differentiation inhibitors

  2011cited by this paper
• Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis

  2011cited by this paper
• Fingolimod: a review of its use in the management of relapsing-remitting multiple sclerosis.

  2011cited by this paper
• Regulation of remyelination in multiple sclerosis

  2011cited by this paper
• Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study

  2011cited by this paper
• FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation

  2010cited by this paper
• Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.

  2010cited by this paper
• Erythropoietin Amplifies Stroke-Induced Oligodendrogenesis in the Rat

  2010cited by this paper
• CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis

  2010cited by this paper
• A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.

  2010cited by this paper
• Myelin Repair Is Accelerated by Inactivating CXCR2 on Nonhematopoietic Cells

  2010cited by this paper
• Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.

  2010cited by this paper
• Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2

  2010cited by this paper
• Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells

  2009cited by this paper
• Bone Marrow Stromal Cells Increase Oligodendrogenesis after Stroke

  2009cited by this paper
• Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination.

  2008cited by this paper
• Niaspan treatment improves neurological functional recovery in experimental autoimmune encephalomyelitis mice.

  2008cited by this paper
• Central nervous system-directed effects of FTY720 (fingolimod).

  2008cited by this paper
• Sourcebook of models for biomedical research

  2008cited by this paper
• Remyelination in the CNS: from biology to therapy

  2008cited by this paper
• FTY720 modulates human oligodendrocyte progenitor process extension and survival

  2008cited by this paper
• The life, death, and replacement of oligodendrocytes in the adult CNS

  2008cited by this paper
• The Proneural Gene Mash1 Specifies an Early Population of Telencephalic Oligodendrocytes

  2007cited by this paper
• LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis

  2007cited by this paper
• Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists

  2007cited by this paper
• The Sonic Hedgehog Pathway Mediates Carbamylated Erythropoietin-enhanced Proliferation and Differentiation of Adult Neural Progenitor Cells*

  2007cited by this paper
• Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells

  2007cited by this paper
• Dose translation from animal to human studies revisited

  2007cited by this paper
• The neurobiology of multiple sclerosis

  2007cited by this paper
• Oral fingolimod (FTY720) for relapsing multiple sclerosis.

  2006cited by this paper
• Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation

  2005cited by this paper
• In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog

  2005cited by this paper
• Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice.

  2005cited by this paper
• The mouse brain in stereotaxic coordinates

  2003cited by this paper
• NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS.

  2003cited by this paper
• Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis

  2003cited by this paper
• Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo

  2003cited by this paper
• Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo

  2003cited by this paper
• The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

  2002cited by this paper
• Why does remyelination fail in multiple sclerosis?

  2002cited by this paper
• Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord.

  2002cited by this paper
• Gli and hedgehog in cancer: tumours, embryos and stem cells

  2002cited by this paper
• Efficient recolonisation of progenitor‐depleted areas of the CNS by adult oligodendrocyte progenitor cells

  2002cited by this paper
• Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine

  2000cited by this paper
• Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis.

  1998cited by this paper

• Understanding the Therapeutic Impact of Disease-Modifying Therapies or No Treatment on Enlarging T1-Weighted Hypointense Lesions and Total T1-Weighted Hypointense Lesion Volume in MS

  2026cites this paper
• Demyelination and Remyelination: General Principles.

  2025cites this paper
• The protective effect of Fingolimod upon visual behavior in a demyelination animal model is associated with synaptopathy prevention.

  2025cites this paper
• RiboTag-based RNA profiling uncovers oligodendroglial lineage-specific inflammation in autoimmune encephalomyelitis: implications for pathogenesis

  2025cites this paper
• Repurposed Drugs to Enhance the Therapeutic Potential of Oligodendrocyte Precursor Cells Derived from Adult Rat Adipose Tissue

  2025cites this paper
• Nerve-Glial antigen 2: unmasking the enigmatic cellular identity in the central nervous system

  2024cites this paper
• ApTOLL: A new therapeutic aptamer for cytoprotection and (re)myelination after multiple sclerosis

  2024cites this paper
• The role of Smo-Shh/Gli signaling activation in the prevention of neurological and ageing disorders

  2023cites this paper
• ApTOLL, a new therapeutic aptamer for cytoprotection and (re)myelination after Multiple Sclerosis

  2023cites this paper
• Supplementary Pharmacotherapy for the Behavioral Abnormalities Caused by Stressors in Humans, Focused on Post-Traumatic Stress Disorder (PTSD)

  2023cites this paper
• Formulating treatment of major psychiatric disorders: algorithm targets the dominantly affected brain cell-types

  2023cites this paper
• Supporting central nervous system neuroprotection and remyelination by specific TLR4 antagonism

  2023cites this paper
• Synthesis and Comprehensive in Vivo Activity Profiling of Olean-12-en-28-ol, 3β-Pentacosanoate in Experimental Autoimmune Encephalomyelitis: A Natural Remyelinating and Anti-Inflammatory Agent

  2023cites this paper
• Purmorphamine, a Smo-Shh/Gli Activator, Promotes Sonic Hedgehog-Mediated Neurogenesis and Restores Behavioural and Neurochemical Deficits in Experimental Model of Multiple Sclerosis

  2023cites this paper
• Enhanced and complementary benefits of a nalfurafine and fingolimod combination to treat immune‐driven demyelination

  2023cites this paper
• Bioavailable central nervous system disease-modifying therapies for multiple sclerosis

  2023cites this paper
• Activation of Shh/Smo is sufficient to maintain oligodendrocyte precursor cells in an undifferentiated state but is not necessary for differentiation

  2023cites this paper
• Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis.

  2023cites this paper
• Hedgehog Signalling Modulates Immune Response and Protects against Experimental Autoimmune Encephalomyelitis

  2022cites this paper
• Chronic demyelination of rabbit lesions is attributable to failed oligodendrocyte progenitor cell repopulation

  2022cites this paper
• Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model

  2022influential citation
• Role of Sonic Hedgehog Signaling Activation in the Prevention of Neurological Abnormalities Associated with Obsessive–Compulsive Disorder

  2022cites this paper
• Fingolimod Nanoemulsions at Different Particle Sizes Define the Fate of Spinal Cord Injury Recovery

  2022cites this paper
• New insights into the immunologic role of oligodendrocyte lineage cells in demyelination diseases

  2022cites this paper
• Abnormal oligodendrocyte function in schizophrenia explains the long latent interval in some patients

  2022cites this paper
• Reversing Alzheimer's disease dementia with clemastine, fingolimod, or rolipram, plus anti‐amyloid therapy

  2022cites this paper
• Remyelination is enhanced by Astragalus polysaccharides through inducing the differentiation of oligodendrocytes from neural stem cells in cuprizone model of demyelination.

  2021cites this paper
• Diffusion Basis Spectrum Imaging Measures Anti-In�ammatory and Neuroprotective Effects of Fingolimod on Murine Optic Neuritis

  2021influential citation
• Effect of fluoxetine treatment on neurotoxicity induced by lysolecithin in male rats.

  2021cites this paper
• Signaling through the S1P−S1PR Axis in the Gut, the Immune and the Central Nervous System in Multiple Sclerosis: Implication for Pathogenesis and Treatment

  2021cites this paper
• Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system.

  2021cites this paper
• A2B Adenosine Receptors and Sphingosine 1-Phosphate Signaling Cross-Talk in Oligodendrogliogenesis

  2021cites this paper
• Diffusion basis spectrum imaging measures anti-inflammatory and neuroprotective effects of fingolimod on murine optic neuritis

  2021cites this paper
• Neuroprotective Effects of Fingolimod Supplement on the Retina and Optic Nerve in the Mouse Model of Experimental Autoimmune Encephalomyelitis

  2021cites this paper
• Bu Shen Yi Sui Capsule Alleviates Neuroinflammation and Demyelination by Promoting Microglia toward M2 Polarization, Which Correlates with Changes in miR-124 and miR-155 in Experimental Autoimmune Encephalomyelitis

  2021cites this paper
• HMGB1 Promotes the Release of Sonic Hedgehog From Astrocytes

  2021cites this paper
• Exploring Sonic Hedgehog Cell Signaling in Neurogenesis: Its Potential Role in Depressive Behavior

  2021cites this paper
• Sphingosine kinase 2 is essential for remyelination following cuprizone intoxication

  2021cites this paper
• Molecular Effects of FDA-Approved Multiple Sclerosis Drugs on Glial Cells and Neurons of the Central Nervous System

  2020influential citation
• Possible regenerative effects of fingolimod (FTY720) in multiple sclerosis disease: An overview on remyelination process

  2020influential citation
• From the Molecular Mechanism to Pre-clinical Results: Anti-epileptic Effects of Fingolimod

  2020cites this paper
• Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis

  2020cites this paper
• Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article

  2020cites this paper
• Fingolimod increases oligodendrocytes markers expression in epidermal neural crest stem cells.

  2020cites this paper
• Sphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation

  2020cites this paper
• Pre-clinical and Clinical Implications of “Inside-Out” vs. “Outside-In” Paradigms in Multiple Sclerosis Etiopathogenesis

  2020cites this paper
• Understanding Abnormal SMO-SHH Signaling in Autism Spectrum Disorder: Potential Drug Target and Therapeutic Goals

  2020cites this paper
• Myeloid‐derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and differentiation

  2020cites this paper
• Multimodal MRI Response to Fingolimod in Multiple Sclerosis: A Nonrandomized, Single Arm, Observational Study

  2020cites this paper
• Immunology of oligodendrocyte precursor cells in vivo and in vitro.

  2019cites this paper
• Effect of fingolimod on oligodendrocyte maturation under prolonged cerebral hypoperfusion.

  2019cites this paper
• MiR-146a promotes oligodendrocyte progenitor cell differentiation and enhances remyelination in a model of experimental autoimmune encephalomyelitis.

  2019cites this paper
• RP001 hydrochloride improves neurological outcome after subarachnoid hemorrhage.

  2019cites this paper
• The Shh receptor Boc is important for myelin formation and repair

  2019cites this paper
• High dose of dexamethasone protects against EAE-induced motor deficits but impairs learning/memory in C57BL/6 mice

  2019cites this paper
• Real-world effectiveness of fingolimod in Polish group of patients with relapsing-remitting multiple sclerosis.

  2019cites this paper
• Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice

  2019cites this paper
• Fingolimod (FTY720) improves the functional recovery and myelin preservation of the optic pathway in focal demyelination model of rat optic chiasm.

  2019cites this paper
• Fingolimod and changes in hematocrit, hemoglobin and red blood cells of patients with multiple sclerosis.

  2019cites this paper
• Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model.

  2019cites this paper
• Thyroid Hormone and the White Matter of the Central Nervous System: From Development to Repair.

  2018cites this paper
• Roles of lysophosphatidic acid and sphingosine-1-phosphate in stem cell biology.

  2018cites this paper
• Fingolimod Enhances Oligodendrocyte Differentiation of Transplanted Human Induced Pluripotent Stem Cell-Derived Neural Progenitors

  2018cites this paper
• Fingolimod reduces the clinical expression of active demyelinating lesions in MS.

  2018cites this paper
• FTY720 (Fingolimod) reverses &agr;‐synuclein‐induced downregulation of brain‐derived neurotrophic factor mRNA in OLN‐93 oligodendroglial cells

  2017cites this paper
• A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials

  2017cites this paper
• The mechanism of action of fingolimod in multiple sclerosis therapy

  2017cites this paper
• Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis

  2017cites this paper
• Mapping Protein Targets of Bioactive Small Molecules Using Lipid-Based Chemical Proteomics.

  2017cites this paper
• Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair.

  2017cites this paper
• Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway

  2017cites this paper
• Fingolimod effects in neuroinflammation: Regulation of astroglial glutamate transporters?

  2017cites this paper
• Targeting sonic hedgehog signaling in neurological disorders

  2017cites this paper
• Fingolimod enhances myelin repair of hippocampus in pentylenetetrazol‐induced kindling model

  2017cites this paper
• Matrine promotes NT3 expression in CNS cells in experimental autoimmune encephalomyelitis.

  2017cites this paper
• LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis

  2017cites this paper
• Effects of FTY720 on brain neurogenic niches in vitro and after kainic acid-induced injury

  2017cites this paper
• Resveratrol Enhances Neurite Outgrowth and Synaptogenesis Via Sonic Hedgehog Signaling Following Oxygen-Glucose Deprivation/Reoxygenation Injury

  2017cites this paper
• Fingolimod Suppresses a Cascade of Core Vicious Cycle in Dry Eye NOD Mouse Model: Involvement of Sphingosine-1-Phosphate Receptors in Infiltrating Leukocytes.

  2017cites this paper
• q-Space Myelin Map imaging for longitudinal analysis of demyelination and remyelination in multiple sclerosis patients treated with fingolimod: A preliminary study.

  2017cites this paper
• q-space Myelin Map imaging: A new imaging technique for treatment evaluation in multiple sclerosis.

  2017cites this paper
• Myeloid cell distribution and activity in multiple sclerosis.

  2016cites this paper
• Inflammation severely alters thyroid hormone signaling in the central nervous system during experimental allergic encephalomyelitis in rat: Direct impact on OPCs differentiation failure

  2016influential citation
• Effects of FTY 720 ( Fingolimod ) on Proliferation , Differentiation , and Migration of Brain-Derived Neural Stem Cells

  2016cites this paper
• Gr upSM Animal experimental models for understanding and treating Multiple Sclerosis

  2016cites this paper
• Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.

  2016cites this paper
• Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation.

  2016cites this paper
• Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.

  2016cites this paper
• Recent achievements in stem cell-mediated myelin repair.

  2016cites this paper
• The sphingosine‐1‐phosphate analogue, FTY‐720, promotes the proliferation of embryonic neural stem cells, enhances hippocampal neurogenesis and learning and memory abilities in adult mice

  2016influential citation
• Fingolimod ameliorates the development of experimental autoimmune encephalomyelitis by inhibiting Akt-mTOR axis in mice.

  2016cites this paper
• Effects of FTY720 (Fingolimod) on Proliferation, Differentiation, and Migration of Brain-Derived Neural Stem Cells

  2016cites this paper
• Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation

  2016cites this paper
• Impact of Mechanotransduction in the Context of Central Nervous System Diseases

  2015cites this paper
• Enhanced remyelination following lysolecithin-induced demyelination in mice under treatment with fingolimod (FTY720).

  2015cites this paper
• Becker Digital

  year unknowninfluential citation